Filton Blood Centre

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Filton Blood Centre North Bristol Park, Filton, Bristol, BS34 7QH Tel: 01179217200 Date of Inspections: 29 January 2014 Date of Publication: February 28 January 2014 2014 We inspected the following standards as part of a routine inspection. This is what we found: Respecting and involving people who use Met this standard services Consent to care and treatment Met this standard Care and welfare of people who use services Met this standard Cleanliness and infection control Met this standard Supporting workers Met this standard Assessing and monitoring the quality of service Met this standard provision | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 1 Details about this location Registered Provider NHS Blood and Transplant Overview of the Filton Blood Centre in Bristol provides specialist scientific service and laboratory services, which the Commission do not regulate. The service collects whole blood and blood component products from voluntary donors and then delivers these to the NHS and other UK health services as directed. We regulate and inspect this part of the service. This inspection was carried out in the Southmead Blood Donor Centre, a permanent site based in the grounds of Southmead Hospital, and one mobile blood donor session. Type of services Acute services with overnight beds Blood and Transplant service Diagnostic and/or screening service Regulated activities Diagnostic and screening procedures Management of supply of blood and blood derived products Treatment of disease, disorder or injury | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 2 Contents When you read this report, you may find it useful to read the sections towards the back called 'About CQC inspections' and 'How we define our judgements'. Page Summary of this inspection: Why we carried out this inspection 4 How we carried out this inspection 4 What people told us and what we found 4 More information about the provider 5 Our judgements for each standard inspected: Respecting and involving people who use services 6 Consent to care and treatment 8 Care and welfare of people who use services 9 Cleanliness and infection control 11 Supporting workers 13 Assessing and monitoring the quality of service provision 15 About CQC Inspections 17 How we define our judgements 18 Glossary of terms we use in this report 20 Contact us 22 | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 3 Summary of this inspection Why we carried out this inspection This was a routine inspection to check that essential standards of quality and safety referred to on the front page were being met. We sometimes describe this as a scheduled inspection. This was an announced inspection. How we carried out this inspection We looked at the personal care or treatment records of people who use the service, carried out a visit on 28 January 2014 and 29 January 2014, observed how people were being cared for and checked how people were cared for at each stage of their treatment and care. We talked with people who use the service, talked with staff and reviewed information given to us by the provider. What people told us and what we found This inspection looked at the services provided from the Blood Donor Centre based within Southmead Hospital and one mobile blood donor session in the community. We were checking that the donor care processes for people who were donating blood (referred to as donors) was safe. We spoke with 12 donors, eight donor carers, three qualified nurses and other senior managers. We found that donors were involved in making decisions about donating, consented to donate and were well looked after during the donation procedure. The health and welfare of donors was paramount and donors were provided with sufficient post-donation information to know what to do if they were unwell. There were stringent procedures in place to ensure that recipients of whole blood and blood component products were not placed at risk of receiving unsafe products. There were standard operating procedures for all staff to follow for the entire whole blood or blood component donation process. This ensured that infection prevention and control measures were in place. Blood donation was carried out in premises that were fit for purpose. Donors were looked after by donor carers and qualified nurses who were well trained and supported to do their job. NHS Blood and Transplant had robust measures in place to monitor the quality and safety of the service and used donor feedback to review and amend service delivery. You can see our judgements on the front page of this report. | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 4 More information about the provider Please see our website www.cqc.org.uk for more information, including our most recent judgements against the essential standards. You can contact us using the telephone number on the back of the report if you have additional questions. There is a glossary at the back of this report which has definitions for words and phrases we use in the report. | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 5 Our judgements for each standard inspected Respecting and involving people who use services Met this standard People should be treated with respect, involved in discussions about their care and treatment and able to influence how the service is run Our judgement The provider was meeting this standard. People were fully informed about the way the service was provided and delivered. People were provided with sufficient information to make an informed choice about participating in donation services. Reasons for our judgement We spoke with five donors at the donor centre and seven donors who attended the mobile blood donation session. Those attending the donor centre were regular platelet donors. They told us "I made the decision to change from being a blood donor so that I could help more patients and donate more often", "I know the drill but every visit the staff check that I am happy to donate. The staff are very professional and courteous" and "I have had to cancel some appointments but the staff are very good at re-arranging my appointments". The donors who attended the mobile blood donation session either had timed appointments to donate or had 'walked-in' to donate. All donors were welcomed and given the Welcome Booklet to read. Those who had never donated before were registered and an explanation was given as to what would happen. New donors were given another booklet to read which explained the blood donation pathway. We found that donors were informed and understood the procedures that were taking place. There was a range of leaflets available for them to provide additional information about the procedures. We saw leaflets in respect of the tests that would be carried out on donated blood, sickle cell & blood donation, over-volume donation, platelet donation and the frequency of male donation. There were also leaflets in respect of feeling faint, bruising, the haemoglobin and iron, finger prick test (explaining why decisions may be made that donation cannot go ahead) and an 'after you have given blood' card. This card gave donors advice about drinking plenty of fluids, not undertaking any strenuous exercise and instructions to leave the donor site plaster in place for a minimum of six hours. We saw these after-care cards being given to donors at the mobile blood donor session. Donor carers and qualified nurses told us that it was always important to explain clearly what was going to happen, even for regular donors. They said "There is a lot of written | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 6 information for donors but we answer questions when we can", "If I have any queries during a donors health screen, I can ask the nurse to speak to the donor" and "Donors are volunteers, therefore it is very important that they are respected and seen on time". | Inspection Report | Filton Blood Centre | February 2014 www.cqc.org.uk 7 Consent to care and treatment Met this standard Before people are given any examination, care, treatment or support, they should be asked if they agree to it Our judgement The provider was meeting this standard. Before people proceeded with donation they were asked for their consent and the provider acted in accordance with their wishes. Reasons for our judgement All donors had to provide written consent before donation of whole blood or blood components could proceed. Those donors who attended the donor centre had to complete and sign their donor health check (DHC) form upon arrival. Whole blood donors in the centre and those donors who attended a booked appointment at a mobile blood donation session, had to hand their completed forms in on arrival. The mobile session had supplies of spare DHC forms for those donors who did not have an appointment or who were new donors. Each donor had a private and confidential health screening consultation and were asked further questions based upon the information they had provided on the DHC. Donors had to again give written consent, signed in the presence of a member of NHS Blood and Transplant staff. Donors consented to say they had read and understood the welcome booklet, were not at risk of infection, agreed to their blood being tested, were aware of the donation process and agreed to their blood being used for the benefit of others. All donors we spoke with, (apart from those who were new blood donors) were fully aware of the nature of the procedures that were going to happen.
Recommended publications
  • NHS Blood and Transplant Annual Report and Accounts 2019/20

    NHS Blood and Transplant Annual Report and Accounts 2019/20

    2019/20 Annual Report HC 773 and Accounts SG/2020/102 2 | ANNUAL REPORT AND ACCOUNTS 2019/20 NHS Blood and Transplant Annual Report and Accounts 2019/20 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 17 September 2020 HC 773 SG/2020/102 ANNUAL REPORT AND ACCOUNTS 2019/20 | 3 © Crown copyright 2020 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3/ Where we have identified any third-party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at: www.gov.uk/official-documents. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, 500 North Bristol Park, Filton, BS34 7QH. ISBN 978-1-5286-2141-0 CCS0920201056 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office Contents Introduction from the Chair ....................................... 6 Corporate governance statement ........................... 57 Overview ................................................................. 8 Parliamentary accountability ................................... 64 Our
  • Transfusion 2024 a Five-Year Plan for Clinical and Laboratory Transfusion

    Transfusion 2024 a Five-Year Plan for Clinical and Laboratory Transfusion

    National Blood Transfusion Committee and NHS Blood and Transplant Transfusion 2024 A Five-year Plan for Clinical and Laboratory Transfusion P1 | Transfusion 2024 National Blood Transfusion Committee and NHS Blood and Transplant FOREWORD Transfusion 2024 is a call to action and provides a plan for us all to push boundaries and achieve the best possible transfusion care for all patients. Transfusion 2024 also marks a defining moment for how the National Blood Transfusion Committee and NHS Blood and Transplant worked together in an inclusive manner. We listened to the diverse views, expertise and experience of our stakeholders, and we are fully committed to continue in this way to deliver Transfusion 2024. Professor Cheng Hock Toh We are both excited about its ambition to improve safety, Chair, National Blood Transfusion Committee experience and outcomes for our patients. This lies at the very heart of modern medicine and we are determined that Transfusion 2024 sets an exemplar of how clinical, laboratory, scientific and technological advances can be embraced efficiently and translated effectively. Its delivery will challenge us all, but we are confident of success because the transfusion community has shown itself to be resilient and adaptable, especially during COVID-19. We are proud to be part of the transfusion community in these uncertain and frightening times; where innovation Dr Gail Miflin and resilience has supported donors, healthcare workers Chief Medical Officer, NHS Blood and Transplant and patients to consolidate the NHS as an exemplary healthcare system that we all can be proud of. Acknowledgements: Our confidence also stems from the rich history of A summary of stakeholders involved pioneering transfusion medicine in the UK, which has in Transfusion 2024 are detailed provided such solid foundations to further build upon.
  • 2019/19 Annual Report and Accounts

    2019/19 Annual Report and Accounts

    Our 2018/19 Annual Report and Accounts HC2301 SG/2019/86 Annual Report and Accounts 2018/19 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 09 July 2019 HC2301 SG/2019/86 © Crown copyright 2019 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government- licence/version/3/ Where we have identified any third-party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at: www.gov.uk/official-documents. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, 500 North Bristol Park, Filton, BS34 7QH. ISBN 978-1-5286-1252-4 CCS – CCS0419046238 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office CONTENTS – THE ANNUAL REPORT AND ACCOUNTS 2018/19 Performance Report ……………………………………………………….……….… 7 Chief Executive’s Foreword ……………………………………………………..…… 9 Performance Analysis………………………………………………………………… 13 Accountability report …………………………………………………………………. 27 Corporate Governance Report…………………………………………….………… 29 Remuneration and Staff Report………………………… ……………………….…. 49 Parliamentary Accountability
  • Triennial Review of NHS Blood and Transplant (NHSBT)

    Triennial Review of NHS Blood and Transplant (NHSBT)

    Triennial Review of NHS Blood and Transplant (NHSBT) Review Report September 2016 Title: Triennial Review of NHS Blood and Transplant; Review Report Authors: Adam McMordie (Lead Reviewer), and Paul McCormack (Assistant Lead Reviewer) – Strategy, System Oversight and Performance Directorate, Finance and Group Operations (17152) Document Purpose: Corporate Report Publication date: 15 September 2016 Target audience: Voluntary groups, Community groups, Charities, Civil society, Advocacy or support organisations, Clinicians, Managers, Commissioners, Directors of Public Health, Pharmacists, Doctors, Midwives, Healthcare scientists, Foundation Trusts, NHS Commissioning Board, Clinical Commissioning Groups, Regulatory body, Academic/ Professional institution, Trade union, General public, Patients, Patients, Service users, Suppliers. Contact details: Triennial Review Programme Team Department of Health 220 Richmond House 79 Whitehall London SW1A 2NS [email protected] You may re-use the text of this document (not including logos) free of charge in any format or medium, under the terms of the Open Government Licence. To view this licence, visit www.nationalarchives.gov.uk/doc/open-government-licence/ © Crown copyright Published to gov.uk, in PDF format only. www.gov.uk/dh 2 Prepared by Lead Reviewer and Assistant Lead Reviewer, Strategy, System Oversight and Performance Directorate, DH 3 Contents Review Report ........................................................................................................................... 1 Contents
  • Controlled If Copy Number Stated on Document and Issued by QA (Template Version 03/02/2020) Page 1 of 45

    Controlled If Copy Number Stated on Document and Issued by QA (Template Version 03/02/2020) Page 1 of 45

    INF136/8 – User Guide for Histocompatibility and Immunogenetics Diagnostics Services Copy No: Effective date: 15/11/2020 HISTOCOMPATIBILITY AND IMMUNOGENETICS DIAGNOSTIC SERVICES USER GUIDE Controlled if copy number stated on document and issued by QA (Template Version 03/02/2020) Page 1 of 45 CONTROLLED INF136/8 – User Guide for Histocompatibility and Immunogenetics Diagnostics Services Copy No: Effective date: 15/11/2020 Contents CONTENTS ............................................................................................................................................. 2 LIST OF FIGURES .................................................................................................................................. 4 LIST OF TABLES ................................................................................................................................... 4 CHAPTER 1: GENERAL INFORMATION.............................................................................................. 5 1.1 THIS GUIDE ................................................................................................................................. 5 1.2 QUALITY STATEMENT ............................................................................................................... 5 1.3 COMPLIMENTS AND COMPLAINTS ......................................................................................... 5 CHAPTER 2: H&I LABORATORIES AND MANAGEMENT ................................................................. 6 2.1.1 OUT OF HOURS .....................................................................................................................
  • NHS Blood and Transplant Annual Report and Accounts 2016/17

    NHS Blood and Transplant Annual Report and Accounts 2016/17

    NHS Blood and Transplant Annual Report and Accounts 2016/17 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 6 July 2017 HC35 SG/2017/75 NHS Blood and Transplant Annual Report and Accounts 2016/17 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 6 July 2017 HC35 SG/2017/75 © NHS Blood and Transplant copyright 2017 The text of this document (this excludes, where present, the Royal Arms and all departmental or agency logos) may be reproduced free of charge in any format or medium provided that it is reproduced accurately and not in a misleading context. The material must be acknowledged NHS Blood and Transplant copyright and the document title specified. Where third party material has been identified, permission from the respective copyright holder must be sought. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, Oak House, Reeds Crescent, Watford, Hertfordshire, WD24 4QN. This publication is available at https://www.gov.uk/government/publications Print ISBN 9781474142335 Web ISBN 9781474142342 ID 22031709 07/17 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the Williams Lea Group on behalf of the Controller of Her Majesty’s Stationery Office CONTENTS - THE ANNUAL REPORT AND ACCOUNTS 2016/17 THE PERFORMANCE REPORT Overview………………………………………………………………………………………….
  • 2019/20 Annual Report and Accounts

    2019/20 Annual Report and Accounts

    2019/20 Annual Report HC 773 and Accounts SG/2020/102 2 | ANNUAL REPORT AND ACCOUNTS 2019/20 NHS Blood and Transplant Annual Report and Accounts 2019/20 Presented to Parliament pursuant to Paragraph 6(3) of Schedule 15 of the National Health Service Act 2006 Laid before the Scottish Parliament by the Scottish Ministers in pursuance of section 88 of the Scotland Act 1998 Ordered by the House of Commons to be printed 17 September 2020 HC 773 SG/2020/102 ANNUAL REPORT AND ACCOUNTS 2019/20 | 3 © Crown copyright 2020 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3/ Where we have identified any third-party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at: www.gov.uk/official-documents. Any enquiries related to this publication should be sent to us at Finance Director, NHS Blood and Transplant, 500 North Bristol Park, Filton, BS34 7QH. ISBN 978-1-5286-2141-0 CCS0920201056 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office Contents Introduction from the Chair ....................................... 6 Corporate governance statement ........................... 57 Overview ................................................................. 8 Parliamentary accountability ................................... 64 Our
  • Item 5.7 Agchc 14 29 Data Access Policy V1 4

    Item 5.7 Agchc 14 29 Data Access Policy V1 4

    AGChC(14)29 NHS BLOOD AND TRANSPLANT ORGAN DONATION AND TRANSPLANTATION DIRECTORATE POLICY FOR ACCESS TO DATA AND INFORMATION THROUGH STATISTICS & CLINICAL STUDIES 1 Introduction and scope In order to fulfil the 2005 Directions (see http://www.odt.nhs.uk/odt/regulation/NHSBT-directions- 2005/), NHS Blood and Transplant (NHSBT) collects, records and analyses data that can be anonymised and/or personally identifiable or sensitive concerning potential and actual organ donors, patients registered for transplant, transplant recipients including long-term follow-up information and individuals registering on the NHS Organ Donor Register. Data collected nationally enables NHSBT to fulfil its statutory obligations with regard to the effective use of organs, equitable organ allocation and performance monitoring of transplant centres in terms of patient and graft outcomes as well as support patients and the public with relevant information in a timely and transparent manner NHSBT receives many requests for data on activity and outcomes to address questions of interest to colleagues engaged in transplantation, the media and other stakeholders. NHSBT is keen to make data available and support the public and health care professionals to access data in a timely and appropriate manner. This policy clarifies how data held by NHSBT can be accessed and used by individuals or groups within NHSBT, with advisory roles to NHSBT, within the wider NHS, from other organisations with an interest in organ donation and transplantation and by members of the public
  • NHSBT ODT Research Process Handbook Copy No: Effective Date: 19/02/2021

    NHSBT ODT Research Process Handbook Copy No: Effective Date: 19/02/2021

    INF1393/5.1 – NHSBT ODT Research Process Handbook Copy No: Effective date: 19/02/2021 NHSBT ODT Research Process Handbook Controlled if copy number stated on document and issued by QA (Template Version 03/02/2020) Page 1 of 31 INF1393/5.1 – NHSBT ODT Research Process Handbook Copy No: Effective date: 19/02/2021 Contents Purpose of Document ............................................................................................................................. 4 Executive Summary ................................................................................................................................ 4 The Research Team ............................................................................................................................... 5 Consent or Authorisation for Research as taken by NHSBT’s Specialist Nurses .................................. 7 By Telephone or Video Call ................................................................................................................ 9 The National Allocation Scheme ............................................................................................................. 9 Hub Operations ................................................................................................................................... 9 Organs Available Through the Scheme ............................................................................................ 10 Anonymity.........................................................................................................................................